Delivery Order SPE2DB22D2006-SPE2DB26FV5WC
- Not listed
- The Defense Logistics Agency awarded a $3,341.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 2, 2025. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA for pharmaceutical and...
- The Defense Logistics Agency awarded a $16,543.30 delivery order (Contract 4569422403) to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $9,925.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and completion targeted for September 26, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. ProQuad is a combination vaccine used for...
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency awarded a $8,059.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The work will be performed in Conshohocken, Pennsylvania, where the contractor maintains...
- The Defense Logistics Agency awarded a delivery order valued at $26,281.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a $1,654.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials under contract 4568957201. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 19, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,543.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product, with a completion date of August 21, 2025. This competitive award (no set-aside used) was issued under a firm fixed-price structure and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5WCDelivery Order
The Defense Logistics Agency awarded a $13,234.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with a completion deadline of November 18, 2025. This is a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order will be fulfilled from the company's Corporate Office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime contract vehicle valued through December 2026 that provides comprehensive pharmaceutical support globally. ProQuad, a combination vaccine used for immunization against measles, mumps, rubella, and varicella, is a critical pharmaceutical commodity within the Defense Health Agency's medical supply chain. AmerisourceBergen's substantial IDC and demonstrated capability to compete for and deliver specialized medical commodities position the company as a key provider of pharmaceutical products and vaccines supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 10/27/25 |